Markston International LLC cut its stake in shares of Aetna Inc. (NYSE:AET) by 5.3% during the second quarter, Holdings Channel reports. The firm owned 305,893 shares of the company’s stock after selling 17,181 shares during the period. Aetna accounts for 3.5% of Markston International LLC’s investment portfolio, making the stock its 2nd largest position. Markston International LLC’s holdings in Aetna were worth $37,358,000 as of its most recent filing with the SEC.
Several other hedge funds also recently made changes to their positions in AET. DAVENPORT & Co LLC boosted its stake in shares of Aetna by 0.3% in the second quarter. DAVENPORT & Co LLC now owns 5,761 shares of the company’s stock valued at $704,000 after buying an additional 18 shares during the period. Rehmann Capital Advisory Group boosted its stake in shares of Aetna by 1.2% in the second quarter. Rehmann Capital Advisory Group now owns 2,209 shares of the company’s stock valued at $270,000 after buying an additional 26 shares during the period. Apex Capital Management boosted its stake in shares of Aetna by 0.5% in the first quarter. Apex Capital Management now owns 5,574 shares of the company’s stock valued at $626,000 after buying an additional 27 shares during the period. Evanson Asset Management LLC boosted its stake in shares of Aetna by 2.6% in the second quarter. Evanson Asset Management LLC now owns 1,951 shares of the company’s stock valued at $238,000 after buying an additional 50 shares during the period. Finally, Pitcairn Co. boosted its stake in shares of Aetna by 1.1% in the second quarter. Pitcairn Co. now owns 5,229 shares of the company’s stock valued at $639,000 after buying an additional 55 shares during the period. Hedge funds and other institutional investors own 91.95% of the company’s stock.
Aetna Inc. (NYSE:AET) traded up 0.45% during midday trading on Wednesday, reaching $116.26. 1,100,437 shares of the company’s stock traded hands. The stock has a market capitalization of $40.78 billion, a price-to-earnings ratio of 17.04 and a beta of 0.62. Aetna Inc. has a 52 week low of $92.42 and a 52 week high of $123.57. The company’s 50-day moving average price is $117.19 and its 200 day moving average price is $115.70.
Aetna (NYSE:AET) last posted its quarterly earnings data on Tuesday, August 2nd. The company reported $2.21 EPS for the quarter, beating analysts’ consensus estimates of $2.12 by $0.09. Aetna had a net margin of 3.89% and a return on equity of 16.44%. The company earned $15.95 billion during the quarter, compared to analyst estimates of $15.69 billion. During the same period in the prior year, the firm earned $2.05 earnings per share. The business’s quarterly revenue was up 4.7% on a year-over-year basis. On average, equities research analysts expect that Aetna Inc. will post $8.05 earnings per share for the current year.
Several brokerages recently commented on AET. Leerink Swann reiterated a “buy” rating and issued a $135.00 price objective on shares of Aetna in a research note on Thursday, August 4th. Zacks Investment Research cut shares of Aetna from a “buy” rating to a “hold” rating in a research report on Monday, August 8th. Morgan Stanley restated a “buy” rating on shares of Aetna in a research report on Tuesday, June 14th. FBR & Co restated a “hold” rating on shares of Aetna in a research report on Wednesday, August 17th. Finally, Sanford C. Bernstein assumed coverage on shares of Aetna in a research report on Thursday, June 16th. They set an “outperform” rating and a $142.00 target price for the company. Seven equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $132.79.
In other Aetna news, Director Jeffrey E. Garten sold 7,100 shares of the company’s stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $116.51, for a total transaction of $827,221.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Shawn M. Guertin sold 45,328 shares of the company’s stock in a transaction dated Tuesday, August 23rd. The shares were sold at an average price of $120.21, for a total transaction of $5,448,878.88. Following the sale, the insider now directly owns 44,883 shares of the company’s stock, valued at $5,395,385.43. The disclosure for this sale can be found here. Company insiders own 0.90% of the company’s stock.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.